ImaginAb and GE Imanet have signed a master service agreement to provide PET imaging agents for drug research.

Inglewood, Calif.-based ImaginAb will utilize GE Imanet’s high sensitivity and high resolution PET infrastructure to develop diagnostic imaging agents based on recombinant antibody fragments. U.K.-based GE Imanet provides assistance for its proof-of-concept radiochemistry, pre-clinical and clinical imaging PET network, which includes over 40 PET research tracers.